Search -

Displaying 41 - 60 of 195

Sort: Relevancy | Date

Presentation THT 2024

HCM Genetics- Prognostic/Therapeutic Implications and Counseling

Presenter: Carolyn Ho

March 04, 2024

Presentation THT 2024

Multimodality Imaging to Phenotype HCM

Presenter: Martin Maron

March 04, 2024

Presentation THT 2024

KEYNOTE: The Spectrum of HCM – Lessons From a Half-Century Journey

Presenter: Christine Seidman

March 04, 2024

Presentation TCT 2023

TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation.

Presenter: Ndausung Udongwo

October 26, 2023

Presentation TCT 2023

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Presenter: Said hajouli

October 26, 2023

Presentation TCT 2023

TCT 437: Transbrachial Right Ventricular Endomyocardial Biopsy – A Patient-Preferred Method

Presenter: Dena Hayes

October 26, 2023

Presentation TCT 2023

TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year?

Presenter: Michael Bashline

October 26, 2023

Presentation TCT 2023

TCT 306: Impact of Cardiac Amyloidosis in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Presenter: Muhammad Junaid Ahsan

October 26, 2023

Presentation TVT 2023

Predictors of Outcome in Transseptal Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Mohamad Saleh Alabdaljabar

June 08, 2023

Presentation TCT 2022

TCT 681: Alcohol Septal Ablation for Preoperative Optimization Prior to Noncardiac Surgery in Hypertrophic Cardiomyopathy

Presenter: Sina Salehi Omran

September 18, 2022

Presentation TVT 2022

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Presenter: David Hsi

June 09, 2022

Presentation ACC 2022

Updated Cumulative Results Of Treatment With Mavacamten From The EXPLORER-LTE Cohort Of The MAVA-LTE Study In Patients With Obstructive Hypertrophic Cardiomyopathy

Presenter: Florian Rader

April 04, 2022

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

Presentation TVT 2021

Hypertrophic Obstructive Cardiomyopathy

Presenter: Paul Sorajja

July 20, 2021

Presentation Controversies and Advances 2019

Echo imaging in HFpEF

Presenter: Jeroen Bax

November 15, 2019

Presentation TCT 2019

Long-term Outcomes of Alcohol Septal Ablation

Presenter: George Hanzel

September 28, 2019

Presentation TCT 2019

Alcohol Septal Ablation Complications and Management

Presenter: Hubert Seggewiss

September 28, 2019

Presentation TCT 2019

The Alcohol Septal Ablation Procedure

Presenter: Valerian Fernandes

September 28, 2019

Presentation TCT 2019

Case Selection for Alcohol Septal Ablation

Presenter: Srihari Naidu

September 28, 2019

Presentation TCT 2019

Clinical Presentation, Pathophysiology, and Natural History

Presenter: Bernard Gersh

September 28, 2019

Advertisement

HCM Genetics- Prognostic/Therapeutic Implications and Counseling

Multimodality Imaging to Phenotype HCM

KEYNOTE: The Spectrum of HCM – Lessons From a Half-Century Journey

TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation.

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

TCT 437: Transbrachial Right Ventricular Endomyocardial Biopsy – A Patient-Preferred Method

TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year?

TCT 306: Impact of Cardiac Amyloidosis in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Predictors of Outcome in Transseptal Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

TCT 681: Alcohol Septal Ablation for Preoperative Optimization Prior to Noncardiac Surgery in Hypertrophic Cardiomyopathy

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Updated Cumulative Results Of Treatment With Mavacamten From The EXPLORER-LTE Cohort Of The MAVA-LTE Study In Patients With Obstructive Hypertrophic Cardiomyopathy

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Hypertrophic Obstructive Cardiomyopathy

Echo imaging in HFpEF

Long-term Outcomes of Alcohol Septal Ablation

Alcohol Septal Ablation Complications and Management

The Alcohol Septal Ablation Procedure

Case Selection for Alcohol Septal Ablation

Clinical Presentation, Pathophysiology, and Natural History

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content